Randomized trial of varicella zoster immune globulin (VZIG) to prevent or modify the course of varicella zoster virus (VZV) infection in pregnant women

1999 ◽  
Vol 65 (2) ◽  
pp. 199-199
Author(s):  
G INOCENCION ◽  
R LOEBSTEIN ◽  
A LALKIN ◽  
R GEIST ◽  
D DALIMONTE ◽  
...  
2002 ◽  
Vol 185 (4) ◽  
pp. 422-427 ◽  
Author(s):  
James H. Harger ◽  
Joseph M. Ernest ◽  
Gary R. Thurnau ◽  
Atef Moawad ◽  
Valerija Momirova ◽  
...  

Author(s):  
Andrew Woodhouse

Chickenpox is caused by varicella-zoster virus and is predominantly a self-limiting disease of childhood. Chickenpox in adults is more likely to be associated with complications such as varicella pneumonia. Treatment with antivirals is helpful in adults if given early after the onset of rash in uncomplicated disease. In complicated disease such as pneumonia, intravenous treatment is essential to optimize drug levels although an evidence base for this is lacking. Exposure to varicella during pregnancy is a particular concern for non-immune women and passive immunization with varicella immune globulin is indicated.


2005 ◽  
Vol 94 (6) ◽  
pp. 790-793 ◽  
Author(s):  
Teresa Murguía-de-Sierra ◽  
Mónica Villa-Guillén ◽  
Dina Villanueva-García ◽  
Antide Molina ◽  
Alejandra Juárez-Chávez ◽  
...  

Vaccines ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. 214
Author(s):  
Claudia M. Trombetta ◽  
Emanuele Montomoli ◽  
Simonetta Viviani ◽  
Rosa Coluccio ◽  
Serena Marchi

Varicella is a highly contagious, infectious disease caused by the varicella-zoster virus. Those at higher risk of severe complications are immunocompromised individuals, adults, non-immune pregnant women, and newborns. According to the gestational time, when varicella-zoster virus infection is acquired during pregnancy, serious complications can potentially occur for both the woman and the fetus. The present study was conducted to assess the profile of varicella susceptibility in pregnant women in Apulia, a large region in Southern Italy, from 2016 to 2019. The data showed that pregnant women between the age of 15–24 and 40–49 years, the youngest and the oldest, respectively, are the most protected against varicella-zoster virus infection, exceeding the prevalence rate of 90%. Conversely, pregnant women between the age of 25 and 34 years seem to be the most vulnerable and the most at risk for acquiring varicella-zoster virus infection during pregnancy. Analysis of the immunity status against varicella should be introduced as a screening test before pregnancy, together with a strategic vaccination campaign targeting non-immune women of childbearing age, in order to reduce the risk of congenital and perinatal varicella.


PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0221084 ◽  
Author(s):  
Grazina Mirinaviciute ◽  
Regine Barlinn ◽  
Susanne Gjeruldsen Dudman ◽  
Elmira Flem

Sign in / Sign up

Export Citation Format

Share Document